Ramin Eskandari, MD
2022 Innovator Award Recipient
Title: Chief of Pediatric Neurosurgery
Institution: Medical University of South Carolina
Dr. Ramin Eskandari’s study is focused on developing a new drug, PSel-Crry 2.3, that targets P-selectin/C3complement at the site of injury to reduce posthemorrhagic hydrocephalus (PHH) and neuroinflammation, leading to improved functional recovery in a hydrocephalus model. The successful outcome of the study will provide insights into the complement system’s role in PHH and advance the field of medical therapeutics for PHH. Thank you to Team Hydro for their generous support of this grant.
This award was supported by Team Hydro.